Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? [Yahoo! Finance]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on RVMD. Revolution Medicines, Inc.'s share was trading at $93.21 as of March 26th. Is RVMD a good stock to buy? Photo by National Cancer Institute on Unsplash Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. RVMD is advancing a differentiated approach to targeting RAS-driven cancers, an area that has historically challenged drug development due to the difficulty of inhibiting protein-protein interactions and the lack of clear binding sites on RAS proteins. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential RAS mutations are among the most common oncogenic drivers across lung, colorectal, and especially pancreatic cancers, yet their biology—particularly the tight binding of GTP/GDP and the predominance of the active RAS(ON) state in tumors—has li
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer GlobeNewswire
- A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Jefferies Highlights Revolution Medicines, Inc. (RVMD)'s RAS(ON) Platform in Coverage Initiation [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
RVMD
Earnings
- 2/25/26 - Miss
RVMD
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/26/26 - Form 4
- 3/26/26 - Form 144
- RVMD's page on the SEC website